![](/img/cover-not-exists.png)
PDB16 COST-EFFECTIVENESS OF BLOOD PRESSURE AND URINARY ALBUMIN CONTROL IN DIABETICS WITH AN ANGIOTENSIN II RECEPTOR ANTAGONIST AND A CALCIUM CHANNEL BLOCKER: PHARMACOECONOMIC ANALYSIS OF THE MARVAL TRIAL-THE CASE OF GERMANY
DG Smith, A Gnanasakthy, K QuednauVolume:
6
Year:
2003
Language:
english
DOI:
10.1016/s1098-3015(10)61740-8
File:
PDF, 66 KB
english, 2003